drugset / Trial / NCT03512236
A Trial to Investigate Pharmacokinetics, Pharmacodynamics, Safety and Tolerability of BioChaperone® Pramlintide Insulin in Patients With Type 1 Diabetes Mellitus
RandomizedCrossoverTriple-blindTreatment
Summary
This is a single center, randomised, double-blind, active comparator controlled, three-period cross-over, single dose trial in subjects with type 1 diabetes mellitus.
Timeline
- Start
- 2018-04-25
- Primary completion
- 2019-02-14
- Completion
- 2019-02-14
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | BC Pram Ins | Unknown | — | Subcutaneous |
| Comparator | Insulin | Protein / enzyme biologic | — | Subcutaneous |
| Comparator | Insulin Lispro | Protein / enzyme biologic | — | Subcutaneous |
| Comparator | Pramlintide | Peptide | — | Subcutaneous |